ANATARA LIFESCIENCES LTD
ASX:ANRPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 96.7% of what they think they own, once every option and right converts.
Runway under 2 quarters; share count grew 64% in 24 months; 2 cash raises in 24 months
ANATARA LIFESCIENCES LTD's ordinary share count grew 64.0% between July 2024 and August 2026, reaching 316M shares. In the past 24 months, the company completed two capital raises totalling A$2.2M, with the most recent being a A$1.2M placement in September 2025. There are currently 11M options on issue, representing 3.4% of the current share count, with the nearest expiry in May 2027; none of these options are currently in the money. As of June 2026, the company reported A$525K in cash, sufficient to cover approximately 1.7 quarters of operating expenses. No proposed securities issues are pending.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 24 Aug 2026 | 2A · quoted issue | ANR : ORDINARY FULLY PAID | 316.3M | Appendix 2A |
| 25 Feb 2026 | 2A · quoted issue | ANR : ORDINARY FULLY PAID | 316.0M | Appendix 2A |
| 11 Dec 2025 | 3H · cancellation | ANR : ORDINARY FULLY PAID | 313.6M | Appendix 3H |
| 26 Nov 2025 | 2A · quoted issue | ANR : ORDINARY FULLY PAID | 313.6M | Appendix 2A |
| 26 Nov 2025 | 3G · unquoted | ANR : ORDINARY FULLY PAID | 247.2M | Appendix 3G |
Capital raises
2 cash raises in the last 24 months · 1 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
- Price-triggered10.5M · 3.3% of sharesOptions and warrants — they convert when the share price clears their exercise price.
- Condition-triggered137k · 0.0% of sharesPerformance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
Exercise price on record: 10.5M priced, 137k where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.
Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.
At $0.009 today, 0 securities are in the money (0.0% of shares on issue). No more priced supply until 3× today’s price, which takes it to 4.0M (1.3% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 137k (1.3% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
- 5.5M more carries an exercise price above ten times today’s — off the right of this axis, and in every total on this page.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| ANRAV | Options | Price-triggered | $0.10 | 6 May 2027 | 2.0M | Filing |
| ANRAX | Options | Price-triggered | $0.075 | 23 Dec 2027 | 1.0M | Filing |
| ANRAW | Options | Price-triggered | $0.10 | 8 July 2028 | 3.5M | Filing |
| ANRAY | Options | Price-triggered | $0.025 | 26 Nov 2028 | 4.0M | Filing |
| ANRAR | Performance rights | Condition-triggered | — | — | 137k | Filing Meeting |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 24 Aug 2026 | John Michailidis | Other incentive | 360k | — | 360k | — | 3Y notice |
| 11 Dec 2025 | Dirk van Dissel | Sell | 6.1M | 850k | — | — | 3Y notice |
| 11 Dec 2025 | Dr David Brookes | Sell | 7.0M | 175k | — | — | 3Y notice |
| 11 Dec 2025 | John Michailidis | Sell | 1.3M | — | 360k | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.